The quinidine sulfate market size is expected to grow by $427.29M from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 6.7% during the forecast period, according to a study by Technavio.
The quinidine sulfate market has been segmented by disease type (malaria and arrhythmias) and geography (North America, Europe, Asia, and Rest of World (ROW)). North America will account for 37% of the market's growth during the forecast period. This growth is attributed to factors such as the increased funding for the development of anti-malarial medicines. However, market growth in this region will be slower than the growth of the market in other regions. The US and Canada are the key countries for the quinidine sulfate market in North America.
The quinidine sulfate market is concentrated, and the vendors are deploying organic and inorganic growth strategies to compete in the market. Vendors in the global quinidine sulfate market are continuously undergoing mergers and acquisitions to broaden their product portfolios and strengthen their positions.